<DOC>
	<DOC>NCT03104933</DOC>
	<brief_summary>This study evaluates the usefulness of pro-adrenomedullin (precursor of a vasodilatory peptide involved in septic shock pathogenesis) and copeptin (a stable peptide of the arginine vasopressin precursor) to predict, at the moment of septic shock diagnosis or their changes at 6 hours, the vasopressor requirements (measured by inotropic index and vasopressor dependency ratio) and volume requirement for resuscitation.</brief_summary>
	<brief_title>Proadrenomedullin and Copeptin in Patients With Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock, Septic</mesh_term>
	<mesh_term>Adrenomedullin</mesh_term>
	<criteria>Patients ≥ 18 years Diagnosis of septic shock Obtaining written informed consent. Initial dose of norepinephrine at ICU admission ≥ 0.6 mg / kg / min. Acute myocardial infarction in the previous month. History of pituitary surgery. Pregnancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Proadrenomedullin</keyword>
	<keyword>Copeptin</keyword>
	<keyword>Vasopressors</keyword>
	<keyword>Septic Shock</keyword>
</DOC>